Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Biokapslen ApS
APS
Bankrupt
CVR 40516492
Hans Egedes Vej 9
Processing of tea and coffee · NACE 1083
Est. 2019
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK 1,4M
+20% vs 2021
EBITDA margin
-22.3%
-128% vs 2021
Equity ratio
-41.1%
Financial strength
Net profit 2022
DKK -290K
-1134% vs 2021
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
DKK 1,4M
+20%
EBITDA
DKK -303K
-128%
Net profit
DKK -290K
-1134%
Total assets
DKK 545K
-9%
Equity
DKK -224K
-442%
Employees
1
—
Company information
Legal name
Biokapslen ApS
CVR number
40516492
Legal form
Anpartsselskab
NACE code
1083 · Processing of tea and coffee
Founded
9. maj 2019
Share capital
DKK 45.714
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed med produktion og salg af kaffekapsler samt enhver i forbindelse hermed stående virksomhed.
Contact
Address
Hans Egedes Vej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Processing of tea and coffee
Companies in Odense
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
1M
2021
1M
2022
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
DKK thousands
Item
2019
2020
2021
2022
Revenue
0
-90
1.131
1.356
Staff expenses
-0
-0
-55
-14
EBITDA
0
-90
-133
-303
Depreciation & amort.
-0
-6
-6
-44
EBIT
0
-96
-139
-346
Net financials
0
-12
123
-25
Profit before tax
0
-108
-16
-372
Tax
-0
-0
-44
-82
Net profit
0
-108
28
-290
Balance sheet
DKK thousands
Item
2019
2020
2021
2022
Total assets
40
321
599
545
Equity
40
-62
66
-224
Long-term debt
0
0
150
150
Short-term debt
0
383
383
619
Total debt
0
383
533
769
Financial ratios
5-year trend
EBITDA margin
-22.3%
This company
15.8%
Market median
-241% vs market
2019
2022
Equity ratio
-41.1%
This company
38.2%
Market median
-208% vs market
2019
2022
Return on equity
-28982800.0%
This company
18.4%
Market median
-157515317% vs market
2019
2022
Net profit margin
-21.4%
This company
8.1%
Market median
-364% vs market
2019
2022
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
2019
2022
Debt / equity
3.43×
This company
0.62×
Market median
-453% vs market
2019
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-05-09 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
RS
Rune Schou
Chairman
2020
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Frederik Korff
Individual
25.0%
25.0%
2020
Jonas Nørrelund Jensen
Individual
25.0%
25.0%
2021
Nana Andersson
Individual
20.0%
20.0%
2020
RUNE SCHOU HOLDING ApS
Company
10.0%
10.0%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Biokapslen ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Rune Schou
Chairman
0 companies